Innovation
46 patent families (37 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport, Physics & computing; filing pace slowing. Cited 1,916 times.
| Year | Filings |
|---|---|
| 2015 | 15 |
| 2016 | 17 |
| 2017 | 16 |
| 2018 | 18 |
| 2019 | 12 |
| 2020 | 11 |
| 2021 | 12 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 1 |
Social engagement
Social engagement: 324 social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Nippon Shokubai, Fushimi Pharmaceutica, Osaka University, MIAT.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Other / undisclosed | 5 | 83% |
Recent activity
24 Jun 2026
Event
BIO2026
12 Jun 2026
Event
BIO2026
22 Apr 2026
Product launch
In Vitro Evolution Peptide Discovery Technology and Lead Discovery Service